Gap Inc\'s (NYSE:GPS) Chief Financial Officer, Katrina O\'Connell, has sold a total of 2,724 shares of the company\'s common stock, according to a recent SEC filing. The transaction was executed at a price of $23.7 per share, resulting in a total value of $64,558. The sale took place on March 18, 2024, and was carried...
XCel Brands, Inc. (NASDAQ:XELB) has seen significant insider activity as Director Mark DiSanto purchased shares worth approximately $95,000. The transaction, which took place on March 15, involved the acquisition of 146,250 shares at a price of $0.65 each. This purchase by DiSanto is noteworthy as it reflects a vote of confidence in the future of...
EVgo Inc. (NASDAQ:EVGO) Chief Legal Officer Francine Sullivan sold 1,400 shares of company stock on March 19, 2024, for a total transaction value of over $3,300. The shares were sold at a price of $2.386 each, according to a recent SEC filing. The transaction has adjusted Sullivan\'s direct holdings in EVgo Inc. to 88,897 shares...
EVgo Inc. (NASDAQ:EVGO), a leading electric vehicle charging network, recently disclosed a transaction by Chief Financial Officer Olga Shevorenkova. According to the filing, Shevorenkova sold 750 shares of Class A Common Stock on March 18, 2024, at a price of $2.4315 per share, totaling over $1,800. The sale comes amidst a period of heightened interest...
In recent transactions, Gail M. Sasaki, the Executive Vice President and Chief Financial Officer of Netlist Inc. (NASDAQ:OTC:NLST), sold a total of 20,830 shares of the company\'s common stock, resulting in proceeds exceeding $35,000. The sales occurred on March 15 and March 18, with prices ranging from $1.580 to $1.815 per share. The first sale...
Liquidia Corp (NASDAQ:LQDA) CEO Roger Jeffs has sold a total of 28,583 shares of company stock, netting over $450,000 in the transaction. The sale, which took place on March 18, 2024, was executed at a price of $15.82 per share. This sale was conducted in accordance with a Rule 10b5-1 trading plan, which Jeffs had...
In a recent transaction on March 18, Scott Moomaw, the Chief Commercial Officer of Liquidia Corp (NASDAQ:LQDA), a pharmaceutical company, sold 6,108 shares of the company\'s common stock. The sale was executed at a price of $15.82 per share, resulting in a total transaction value of $96,628. This sale was conducted under a pre-arranged trading...
In a recent filing with the Securities and Exchange Commission, Michael Kaseta, the Chief Financial Officer and Chief Operating Officer of Liquidia Corp (NASDAQ:LQDA), reported selling a total of 12,166 shares of company stock for an average price of $15.82 per share, amounting to over $192,466 in total proceeds. The transactions occurred on March 18,...
In a recent transaction, Dr. Rajeev Saggar, Chief Medical Officer of Liquidia Corp (NASDAQ:LQDA), sold a significant number of shares in the company. The transaction, which took place on March 18, 2024, involved the sale of 7,530 shares of common stock at a price of $15.82 per share, amounting to a total of approximately $119,124....
ADMA Biologics, Inc. (NASDAQ:ADMA) has seen a significant sale of its stock by Director Steve Elms, according to a recent SEC filing. Elms, who is associated with Aisling Capital II LP, disposed of a total of 460,716 shares of the company\'s common stock over two separate transactions on March 18 and March 19, 2024. The...